Both Sjögren's syndrome (SS) and non-Sjögren's syndrome (NSS) can present with the sicca symptoms of dry eyes and a dry mouth but they are distinct pathological entities that require diagnostic discrimination. This study included 82 sicca syndrome patients and examined the ability of sialoscintigraphy and antibodies against the autoantigens a-fodrin, Ro and La to discriminate between SS and NSS. A total of 30.8% of SS patients compared with 58.8% of NSS patients were a-fodrin positive. The prevalence of Ro positivity was 69.4% for SS patients compared with 0% for NSS patients. The prevalence of La positivity was 52.4% for SS compared with 0% for NSS patients. Sialoscintigraphy showed that more NSS patients had grade III salivary gland impairment compared with SS patients (64.7% versus 19.4%). These data suggest that using sialoscintigraphy in combination with measuring the levels of serum a-fodrin, Ro and La might be useful for SS and NSS discrimination.
Introduction
Both Sjögren's syndrome (SS) and non-Sjögren's syndrome (NSS) can show the clinical sicca symptoms of dry eyes and a dry mouth. 1 SS is an autoimmune exocrinopathology characterized by lymphoid cell infiltration and destruction of salivary and lacrimal glands. 2 Patient complaints include xerostomia and xerophthalmia, which are generally recognized as sicca symptoms. 3 The diagnostic criteria of SS include dry eyes, a dry mouth, objective evidence of dry eyes, objective evidence of a dry mouth, the presence of serum SS-A/Ro and SS-B/La autoantigens, and a focal sialadenitis of the labial salivary glands. 4 There are two types of SS: primary SS is not associated with other underlying autoimmune diseases, whereas secondary SS is associated with, or occurs with, another autoimmune disease such as rheumatoid arthritis, scleroderma, or systemic lupus erythematosus. 5 The autoantigens Ro and La are widely used as markers for the diagnosis of SS, 6 but K-S Chen, M-C Jiang, C-J Li et al. Discrimination between Sjögren's and non-Sjögren's syndrome the prevalence of Ro and La positivity may only be around 30% in SS patients. 7 A large study has failed to show an association between Ro/La autoantigens and the symptoms of dry eyes or a dry mouth in SS patients. 8 The autoantigen, α-fodrin, has been postulated to be involved in the autoimmune responses leading to glandular destruction of lacrimal and salivary glands. 9 The presence of α-fodrin autoantigen has been found in 93% of primary SS patients, 10 and it has been reported that α-fodrin is a specific and sensitive marker for SS diagnosis. 11 Accumulated studies have, however, shown that there is some debate about the prevalence of α-fodrin autoantigen positivity in SS patients, which ranges from approximately 20% to 98%. 12 Ruffatti et al. 13 reported that the sensitivity of immunoglobulin G (IgG) antibodies against α-fodrin for primary SS was only 21.25%. Zandbelt et al. 14 also reported that anti-αfodrin antibodies do not add much to the diagnosis of SS.
Non-Sjögren's syndrome occurs when the lacrimal or salivary glands are damaged but, unlike SS, NSS is not caused by an autoimmune disorder. 15 The most serious aspect of SS is the increased risk for developing malignant neoplasms. 16, 17 Establishing the criteria for SS and NSS discrimination is, therefore, extremely important. The presence of α-fodrin autoantigen in the serum of NSS patients owing to the damage to lacrimal and salivary glands, and the use of sialoscintigraphy to discriminate between SS and NSS patients has not been fully studied. In the present study the serum levels of the autoantigens, α-fodrin, Ro and La, in SS and NSS patients were measured in order to determine whether they could be used to discriminate between these two syndromes.
The severity of salivary gland impairment evaluated by sialoscintigraphy in both groups of patients was also determined. 
Patients and methods

PATIENTS
MEASUREMENT OF SERUM LEVELS OF AUTOANTIGENS a-FODRIN, RO AND LA
Serum α-fodrin was measured using IgG antibodies against α-fodrin with an α-fodrin-G enzyme-linked immunosorbent assay (ELISA) kit (Aeskulisa ® ; Aesku Diagnostics, Wendelsheim, Germany) according to the manufacturer's instructions. Serum Ro and K-S Chen, M-C Jiang, C-J Li et al.
Discrimination between Sjögren's and non-Sjögren's syndrome
La levels were measured using IgG antibodies against Ro and La (EliA™ Ro and EliA™ La kits; Phadia AB, Uppsala, Sweden) and a Thermo Multiskan ® EX Microplate Photometer (Thermo Fisher Scientific, Waltham, MA, USA) following the manufacturer's instructions. Each sample was assayed in duplicate. The standard range for the α-fodrin-G ELISA kit was 0 -300 U/ml and a value ≥ 15 U/ml was regarded as positive according to the manufacturer's instructions. The standard range for the EliA™ Ro and EliA™ La kits was 0 -320 U/ml and a value ≥ 7 U/ml was regarded as positive.
SIALOSCINTIGRAPHY
Briefly, sour plum (200 mg) was placed on the dorsal surface of the tongue for salivary stimulation 20 min after an IV injection of 15 mCi free technetium-99m. Sequential images over the anterior view of the head were acquired at 1 min per frame for 40 min. Salivary gland impairment was graded: 0, no dryness; I, occasional dryness; II, partial but persistent dryness; III, complete dryness but non-debilitating; and IV, complete dryness and debilitating.
STATISTICAL ANALYSIS
Data were analysed using SPSS ® statistical software, version 15.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Differences in continuous variables were analysed by the Mann-Whitney U-test, and differences in categorical variables were analysed by Fisher's exact test and the χ 2 test. A discriminant function analysis was also carried out. A P-value of < 0.05 was considered to be statistically significant.
Results
A total of 82 sicca syndrome patients were enrolled in the study: 45 primary SS patients Fig. 2A ). The mean serum α-fodrin level was also significantly higher in the NSS patients compared with all SS patients (P = 0.006) and compared with primary SS patients (P = 0.05), but not compared with secondary SS patients (Fig. 2B) * Discrimination between Sjögren's and non-Sjögren's syndrome [20/43] Fig. 3D ). Discriminant function analysis for sialoscintigraphy, and serum α-fodrin, Ro and La levels demonstrated that serum Ro and La levels, but not serum αfodrin levels or sialoscintigraphy, had significant discriminant function between SS and NSS patients ( Table 3) .
Discussion
Sialoscintigraphy can provide information about salivary gland function and has been used in the quantitative evaluation of the 19, 20 The sicca symptoms associated with SS result when the patient's immune system attacks their salivary and lacrimal glands. 21 These attacks may be very mild or negligible when expression of the autoantigen in the glands, which is the molecular target of the autoimmune response, is low. 22 Whilst many SS patients may not even show sicca symptoms, 23 NSS patients definitely show them because of impairment of the function of their lacrimal or salivary glands. 22 The finding in the present study that more NSS patients had grade III salivary gland impairment compared with the SS patients as shown by sialoscintigraphy was not, therefore, unexpected.
The present study showed a lower prevalence of serum α-fodrin positivity and a higher prevalence of serum Ro and La positivity in SS patients compared with NSS patients. This result is similar to that of a previous report that demonstrated that antiα-fodrin antibody positivity was not diagnostically superior to conventional anti-Ro/La testing. 24 In contrast, another study reported that anti-α-fodrin antibodies could be used as a diagnostic marker for childhood primary SS, which suggests that α-fodrin may be an early diagnostic marker for SS. 25 Most SS patients experience a delay of 10 -12 years from the onset of symptoms to the final diagnosis of SS. 26 Why the prevalence of αfodrin positivity was higher in NSS patients compared with SS patients in the present study is not known. If follow-up diagnosis of the 17 NSS patients were to show that the condition of most of these NSS patients developed into SS in the future, then α-fodrin may have some prognostic value as a marker for the early detection of SS in adults. For the time being, however, the reliability and sensitivity of α-fodrin for determining SS diagnosis remains debatable. Besides SS, αfodrin is also present in the serum of patients with other related diseases, such as glaucoma and Graves' ophthalmopathy. 27, 28 Thus, it is perhaps not surprising that a higher prevalence of α-fodrin positivity was detected in the NSS patients in the present study.
A recent study reported that anti-Ro/La autoantibodies can access the cells of the salivary gland and trigger apoptosis. 29 The involvement of Ro/La and the immune system in the apoptosis of the salivary gland cells of SS patients, but not of NSS patients, may explain why serum Ro and La positivity was higher in SS patients compared with NSS patients in the present study.
In conclusion, more NSS patients had grade III salivary gland impairment, as determined by sialoscintigraphy, compared with SS patients. There were differences between the two groups of patients in terms of the prevalence of serum α-fodrin positivity and the mean serum α-fodrin level, as well as serum Ro/La positivity and the mean serum Ro/La levels. Thus, sialoscintigraphy in combination with measuring the serum levels of the autoantigens, α-fodrin, Ro and La, might be useful for discrimination between SS and NSS. A long-term diagnostic follow-up for ≥ 10 years is required to verify whether α-fodrin is an early marker for the development of SS in adults.
